ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
109.87
-2.03 (-1.81%)
At close: Apr 28, 2026, 4:00 PM EDT
110.83
+0.96 (0.87%)
After-hours: Apr 28, 2026, 4:03 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.86 billion as of April 28, 2026. Its market cap has increased by 2,242.57% in one year.
Market Cap
8.86B
Enterprise Value
8.28B
1-Year Change
2,242.57%
Ranking
Category
Stock Price
$109.87
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.86B, an increase of 3,829.41%. That is a compound annual growth rate of 40.29%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arrowhead Pharmaceuticals | 10.35B |
| BioMarin Pharmaceutical | 10.23B |
| Praxis Precision Medicines | 9.60B |
| Axsome Therapeutics | 9.51B |
| Vaxcyte | 8.56B |
| Bio-Techne | 8.48B |
| Nuvalent | 8.22B |
| Cytokinetics | 8.12B |